Clamentrin

Clamentrin

CLAMENTRIN POWDER FOR ORAL SUSPENSION is indicated for the treatment of paediatric patients with:

– Acute Otis media due to Streptococcus pneumoniae, Haemophillus influenzae and Moraxella catarrhalis

– Community acquired pneumonia caused or thought to be caused by Streptococcus pneumoniae

Such patients are often characterised by:
– Antibiotic exposure for acute otitis media within the preceding 3 months and are either aged < 2 years or attend day-care.

Download PI

Composition

Each 5 ml suspension contains amoxicillin trihydrate equivalent to 600 mg amoxicillin and potassium clavulanate equivalent to 42,90 mg clavulanic acid.

Product also contains the following inactive ingredients:

Acesulfam potassium, carmellose sodium, crospovidone Type A, saccharin sodium, silica colloidal anhydrous, silicon dioxide, strawberry flavour (flavouring components, maize maltodextrin, propylene glycol, triethyl citrate), xanthan gum.